Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Asset Writedowns and Impairment (2018 - 2023)

Viemed Healthcare filings provide 6 years of Asset Writedowns and Impairment readings, the most recent being $4.1 million for Q1 2023.

  • On a quarterly basis, Asset Writedowns and Impairment rose 19.91% to $4.1 million in Q1 2023 year-over-year; TTM through Mar 2023 was $10.7 million, a 25.54% increase, with the full-year FY2022 number at $10.0 million, up 45.19% from a year prior.
  • Asset Writedowns and Impairment hit $4.1 million in Q1 2023 for Viemed Healthcare, up from $2.2 million in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $4.1 million in Q1 2023 to a low of $1.5 million in Q3 2020.
  • Median Asset Writedowns and Impairment over the past 5 years was $2.1 million (2019), compared with a mean of $2.4 million.
  • Biggest five-year swings in Asset Writedowns and Impairment: tumbled 52.79% in 2020 and later soared 89.39% in 2022.
  • Viemed Healthcare's Asset Writedowns and Impairment stood at $2.9 million in 2019, then fell by 27.45% to $2.1 million in 2020, then decreased by 21.1% to $1.6 million in 2021, then soared by 33.74% to $2.2 million in 2022, then surged by 87.77% to $4.1 million in 2023.
  • The last three reported values for Asset Writedowns and Impairment were $4.1 million (Q1 2023), $2.2 million (Q4 2022), and $1.5 million (Q3 2022) per Business Quant data.